Research and Markets (http://www.researchandmarkets.com/research/6nh6r2/global_cystic) has announced the addition of the "Global Cystic Fibrosis Market 2015-2019" report to their offering.
The analysts forecast the Global Cystic Fibrosis market to grow at a CAGR of 32.5% over the period 2014-2019
Cystic fibrosis also known as mucoviscidosis is a genetically-inherited disease. It is one of the most common genetic disorders found in the Caucasian children. The incidence of cystic fibrosis varies among populations, and is substantially less common in Asian and African populations as compared to the people of Caucasoid origin of Europe and North America, with a marked difference within each country.
CFTR modulator drugs are increasingly becoming the preferred choice of treatment for cystic fibrosis as these drugs target the molecular cause of cystic fibrosis. Since these drugs target the cause of the disease, they are gaining popularity among patients and the medical community as a preferred choice for the treatment of cystic fibrosis.
According to the report, the primary driver of this market is the high degree of unmet needs for appropriate drugs in the market. There is no cure for cystic fibrosis and the mortality rate is high. Therefore, drugs that can achieve remission of the disease in patients are expected to drive the growth of the market.
Further, the report states that the high cost of therapy is a major factor that restricts the growth of the market. Patients tend to withdraw from treatment, deterred by the high costs. Medication and hospitalization costs account for the largest share of the expenditure of a cystic fibrosis patient, followed by medical services, costs resulting from other complications, and diagnostic charges. This results in high overall expenditure.
The report considers the revenue generated from the sales of various generic and branded therapies used in the treatment of cystic fibrosis which includes:
- Small Molecules
- Biologics
Key Vendors
- Actavis
- F. Hoffmann-La Roche
- Gilead Sciences
- Novartis
- Vertex Pharmaceuticals
Key Topics Covered:
- Executive Summary
- List of Abbreviations
- Scope of the Report
- Product Profiles
- Market Research Methodology
- Introduction
- Disease Overview
- Market Landscape
- Market Segmentation by Molecule Type
- Market Segmentation by Route of Administration
- Market Segmentation by Dosage Form
- Geographical Segmentation
- Key Leading Countries
- Buying Criteria
- Market Growth Drivers
- Drivers and their Impact
- Market Challenges
- Impact of Drivers and Challenges
- Market Trends
- Trends and their Impact
- Vendor Landscape
- Key Vendor Analysis
For more information visit http://www.researchandmarkets.com/research/6nh6r2/global_cystic